Hong Ren

11.2k total citations
310 papers, 5.4k citations indexed

About

Hong Ren is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hong Ren has authored 310 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Epidemiology, 135 papers in Hepatology and 59 papers in Molecular Biology. Recurrent topics in Hong Ren's work include Hepatitis B Virus Studies (130 papers), Hepatitis C virus research (112 papers) and Liver Disease Diagnosis and Treatment (83 papers). Hong Ren is often cited by papers focused on Hepatitis B Virus Studies (130 papers), Hepatitis C virus research (112 papers) and Liver Disease Diagnosis and Treatment (83 papers). Hong Ren collaborates with scholars based in China, United States and Germany. Hong Ren's co-authors include Peng Hu, Huaidong Hu, Dazhi Zhang, Huaidong Hu, Jingyuan Xie, Weiming Wang, Mingli Peng, Yixuan Yang, Xiaoxia Pan and Hu Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Hong Ren

295 papers receiving 5.3k citations

Peers

Countries citing papers authored by Hong Ren

Since Specialization

Citations

This map shows the geographic impact of Hong Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Ren more than expected).

Fields of papers citing papers by Hong Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Ren. The network helps show where Hong Ren may publish in the future.

Co-authorship network of co-authors of Hong Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Ren. A scholar is included among the top collaborators of Hong Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Ren. Hong Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Activation of the Jak2/Stat3 pathway by ROS-dependent signaling cascades initiates hepatitis B virus-induced hepatic inflammatory responses 2025 ·Genes & Diseases ·Rui Song, Shasha Yu, Xueyan Chen, (unknown), Dachuan Cai, Hong Ren, (unknown)	0
2	Chinese Clinical Practice Guidelines for the Prevention and Treatment of Mother-to-child Transmission of Hepatitis B Virus (Version 2024) 2024 ·Journal of Clinical and Translational Hepatology ·Jinfeng Liu, Qing‐Lei Zeng, Fanpu Ji, Hong Ren, (unknown), Lanjuan Li, Yingren Zhao	1
3	Clinical and immunological features of COVID‐19 in patients with anti‐MDA5 dermatomyositis during the omicron wave in Chongqing, China 2024 ·Journal of Medical Virology ·Na Wu, Zhiwei Chen, (unknown), (unknown), Wenhan Huang, Dachuan Cai, Mingli Peng, Peng Hu, Lin Tang, Hong Ren	1
4	A Targeted-Release Formulation of Budesonide for the Treatment of IgA Nephropathy Patients With Severe Renal Impairment 2024 ·Kidney International Reports ·Yan Ouyang, (unknown), M. Chen, Junru Li, (unknown), Qing Zhao, Hong Ren, Jiali Wei, Nan Chen, Xiaoxia Pan, Jingyuan Xie	1
5	Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis 2023 ·Clinical Kidney Journal ·Wen Du, Zijin Chen, (unknown), Junru Li, Qinjie Weng, (unknown), (unknown), (unknown), Xiangchen Gu, Hao Shi, Zhaohui Wang, Hong Ren, Weiming Wang, Yan Ouyang, Jingyuan Xie	2
6	Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China 2023 ·Frontiers in Public Health ·Yijun Wang, Min Shu, Jun Chen, (unknown), Hong Ren, Yongfu Yu	2
7	Prevalence of and risk factors for high-altitude hyperuricaemia in Bai individuals: a cross-sectional study 2021 ·Journal of International Medical Research ·(unknown), Zijin Chen, Jun Ma, Jingyuan Xie, (unknown), Hong Ren, Xiaonong Chen	10
8	Serum pre‐albumin is prognostic for all‐cause mortality in patients with community‐acquired and post‐operative acute kidney injury 2019 ·Internal Medicine Journal ·(unknown), Jingyuan Xie, Pingyan Shen, (unknown), Xiaobo Ma, Xiaonong Chen, Hong Ren, Wen Zhang	1
9	A baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients with chronic hepatitis B 2018 ·Alimentary Pharmacology & Therapeutics ·Henry Lik‐Yuen Chan, Diethelm Messinger, George Papatheodoridis, Markus Cornberg, Qing Xie, Teerha Piratvisuth, Hong Ren, Patrick Kennedy, A. Thompson, (unknown), Georgios Bakalos, Vedran Pavlovic, Pietro Lampertico	22
10	Entecavir-based combination therapies for chronic hepatitis B 2018 ·Medicine ·Aoran Luo, Xiaoyan Jiang, Hong Ren	1
11	[Current status of treatment of chronic hepatitis C and related challenges in the "Pre-DAA Era" in China]. 2016 ·PubMed ·Peng Hu, Hong Ren	5
12	Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population 2016 ·Journal of Human Genetics ·(unknown), Hua Yang, Qiufang Liu, (unknown), Feng Tian, Yongri Ouyang, Tianbo Jin, Hong Ren	10
13	Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data 2016 ·Scientific Reports ·Zhiwei Chen, Hu Li, Hong Ren, Peng Hu	76
14	Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score 2012 ·PLoS ONE ·Jingyuan Xie, Krzysztof Kiryluk, Weiming Wang, Zhaohui Wang, (unknown), Pingyan Shen, Hong Ren, Xiaoxia Pan, Xiaonong Chen, Wen Zhang, Xiao Li, Hao Shi, Yifu Li, Ali G. Gharavi, Nan Chen	116
15	Association between Serum Platelet-Derived Growth Factor BB and Degree of Liver Damage, Fibrosis and Hepatitis B e Antigen (HBeAg) Status in CHB Patients 2012 ·Hepatogastroenterology ·(unknown), (unknown), Yufang Li, Xiaoyan Liu, Xu Zhang, Junying Liu, (unknown), Dazhi Zhang, Huaidong Hu, Hong Ren	12
16	Overexpression of Smac Promotes Cisplatin-Induced Apoptosis by Activating Caspase-3 and Caspase-9 in Lung Cancer A549 Cells 2012 ·Cancer Biotherapy and Radiopharmaceuticals ·Sida Qin, Chengcheng Yang, Xifang Wang, (unknown), Shuo Li, Boxiang Zhang, Hong Ren	22
17	Biomarkers in the Lung Cancer Diagnosis: A Clinical Perspective 2012 ·Neoplasma ·Xiaodong Li, (unknown), Lian Gao, (unknown), Zhengxun Song, (unknown), Hong Ren, Tao Yang, (unknown), (unknown)	51
18	714 THREE-YEARS OF CONTINUOUS TREATMENT WITH ENTECAVIR RESULTS IN HIGH PROPORTIONS OF CHINESE NUCLEOSIDE-NAIVE PATIENTS WITH UNDETECTABLE HBVDNA: RESULTS FROM STUDIES ETV-023 AND -050 2008 ·Journal of Hepatology ·(unknown), (unknown), Hong Ren, (unknown), (unknown), (unknown), (unknown), (unknown), Dong Xu, Cyril Llamoso	4
19	518 Entecavir results in early viral load reduction in chronic hepatitis B patients who have failed lamivudine therapy: A randomized, placebo-controlled study in China 2006 ·Journal of Hepatology ·(unknown), Xiaoling Zhou, Da-Zhong Xu, (unknown), Hong Ren, Meng Jiang, (unknown), (unknown), (unknown)	1
20	Study on training university students of construction management in the 21st century 2006 ·(unknown), Hong Ren	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact